Skip to content

Clinical trials

Asthma trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Country / region: Spain Clear all

210 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20043
20056
20065
20076
20083
20093
20104
201111
20126
201311
201414
201514
201614
20178
201814
20191
202010
202116
202210
202315
202415
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed139
Unknown status20
Recruiting16
Terminated13
Active, not recruiting11
Not yet recruiting4
Enrolling by invitation3
Withdrawn3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca41
GlaxoSmithKline27
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau18
Sanofi13
Novartis Pharmaceuticals12
Chiesi Farmaceutici S.p.A.10
Teva Branded Pharmaceutical Products R&D, Inc.6
Hoffmann-La Roche5
Inmunotek S.L.4
Laboratorios Leti, S.L.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma210
Lung Diseases14
Pulmonary Disease, Chronic Obstructive13
Hypersensitivity11
Respiratory Tract Diseases11
Pulmonary Eosinophilia10
Bronchial Diseases9
Lung Diseases, Obstructive8
Rhinitis, Allergic8
Diabetes Mellitus, Type 14

Trials

Showing 1 to 25 of 210. Each trial links to its page on Pharma Observatory.

110 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.